Robotic stereotactic treatment for malignant metastasis of solid tumour in the pancreas: A multiple case report and review of literature

Publication date: Available online 11 November 2017
Source:Cancer/Radiothérapie
Author(s): M. Loi, A. Magallon-Baro, C. Papalazarou, M. Milder, J.J. Nuyttens
Metastatic involvement of the pancreas occurs in 5% of patients affected by advanced malignancies. Surgical resection has been reported by number of authors as a valuable option to improve disease control, in particular in patients with limited disease burden and favourable histotypes; however, the benefit of this procedure has been questioned due to patient selection, technical challenges and relevant risk of perioperative mortality and severe complications. In the present study, a cohort of surgically unfit patients affected by a solitary metastasis in the pancreas from various primary tumours received stereotactic radiotherapy with an ablative dose schedule, obtaining promising local and distant disease progression-free delay with minor toxicity. This is the first report to our knowledge on the use of ablative stereotactic radiotherapy of metastasis in the pancreatic gland.



http://ift.tt/2hsFNWw